Janus Henderson Group PLC Takeda Pharmaceutical CO LTD Transaction History

Janus Henderson Group PLC

  • $188 Billion
  • Q4 2024

A detailed history of Janus Henderson Group PLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Janus Henderson Group PLC holds 233,950 shares of TAK stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
233,950
Previous 256,447 8.77%
Holding current value
$3.17 Million
Previous $3.64 Million 15.01%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$13.01 - $14.43 $292,685 - $324,631
-22,497 Reduced 8.77%
233,950 $3.1 Million
Q3 2024

Nov 14, 2024
SELL
$13.0 - $15.08 $687,323 - $797,294
-52,871 Reduced 17.09%
256,447 $3.64 Million
Q2 2024

Aug 14, 2024
BUY
$12.6 - $13.67 $1.41 Million - $1.53 Million
111,894 Added 56.68%
309,318 $4 Million
Q1 2024

May 15, 2024
SELL
$13.89 - $15.04 $650,440 - $704,293
-46,828 Reduced 19.17%
197,424 $2.74 Million
Q4 2023

Feb 14, 2024
SELL
$13.36 - $15.43 $1.92 Million - $2.22 Million
-143,766 Reduced 37.05%
244,252 $3.49 Million
Q3 2023

Nov 14, 2023
SELL
$15.03 - $16.32 $131,557 - $142,848
-8,753 Reduced 2.21%
388,018 $6 Million
Q2 2023

Aug 14, 2023
SELL
$15.57 - $17.11 $234,281 - $257,454
-15,047 Reduced 3.65%
396,771 $6.23 Million
Q1 2023

May 15, 2023
SELL
$15.28 - $16.48 $242,065 - $261,076
-15,842 Reduced 3.7%
411,818 $6.79 Million
Q4 2022

Feb 14, 2023
SELL
$12.42 - $15.62 $179,667 - $225,958
-14,466 Reduced 3.27%
427,660 $6.68 Million
Q3 2022

Nov 14, 2022
SELL
$12.8 - $28.65 $191,347 - $428,288
-14,949 Reduced 3.27%
442,126 $5.73 Million
Q2 2022

Aug 15, 2022
SELL
$13.12 - $15.03 $140,187 - $160,595
-10,685 Reduced 2.28%
457,075 $6.42 Million
Q1 2022

May 16, 2022
BUY
$13.54 - $15.35 $784,643 - $889,532
57,950 Added 14.14%
467,760 $6.7 Million
Q4 2021

Feb 14, 2022
SELL
$13.17 - $16.4 $732,383 - $912,003
-55,610 Reduced 11.95%
409,810 $5.59 Million
Q3 2021

Nov 16, 2021
SELL
$16.3 - $17.26 $1.81 Million - $1.92 Million
-111,214 Reduced 19.29%
465,420 $7.62 Million
Q2 2021

Aug 16, 2021
SELL
$16.55 - $18.64 $1.24 Million - $1.4 Million
-74,960 Reduced 11.5%
576,634 $9.71 Million
Q1 2021

May 17, 2021
BUY
$16.71 - $19.9 $1.16 Million - $1.38 Million
69,243 Added 11.89%
651,594 $11.9 Million
Q4 2020

Feb 16, 2021
SELL
$15.39 - $18.97 $1.83 Million - $2.25 Million
-118,798 Reduced 16.94%
582,351 $10.6 Million
Q3 2020

Nov 16, 2020
SELL
$17.1 - $19.19 $933,454 - $1.05 Million
-54,588 Reduced 7.22%
701,149 $12.5 Million
Q2 2020

Aug 14, 2020
BUY
$14.59 - $19.5 $293,813 - $392,691
20,138 Added 2.74%
755,737 $13.6 Million
Q1 2020

May 14, 2020
SELL
$13.02 - $20.31 $6.19 Million - $9.65 Million
-475,057 Reduced 39.24%
735,599 $11.2 Million
Q4 2019

Feb 18, 2020
SELL
$16.88 - $20.83 $3.64 Million - $4.5 Million
-215,825 Reduced 15.13%
1,210,656 $23.9 Million
Q3 2019

Nov 14, 2019
SELL
$16.15 - $17.99 $872,196 - $971,567
-54,006 Reduced 3.65%
1,426,481 $24.5 Million
Q2 2019

Jul 31, 2019
BUY
$16.58 - $20.49 $283,302 - $350,112
17,087 Added 1.17%
1,480,487 $26.2 Million
Q1 2019

Apr 30, 2019
BUY
$16.7 - $21.52 $13 Million - $16.8 Million
781,068 Added 114.47%
1,463,400 $29.8 Million
Q4 2018

Feb 06, 2019
BUY
$15.64 - $21.1 $10.7 Million - $14.4 Million
682,332 New
682,332 $11.5 Million

Others Institutions Holding TAK

# of Institutions
335
Shares Held
69.1M
Call Options Held
1.99M
Put Options Held
171K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email